0000904454-13-000824.txt : 20130716 0000904454-13-000824.hdr.sgml : 20130716 20130716203404 ACCESSION NUMBER: 0000904454-13-000824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130715 FILED AS OF DATE: 20130716 DATE AS OF CHANGE: 20130716 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocera Therapeutics, Inc. CENTRAL INDEX KEY: 0001274644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 631192270 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12651 HIGH BLUFF DRIVE STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-436-3900 MAIL ADDRESS: STREET 1: 12651 HIGH BLUFF DRIVE STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TRANZYME INC DATE OF NAME CHANGE: 20031230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOVEY BRIAN H CENTRAL INDEX KEY: 0001207786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35119 FILM NUMBER: 13971368 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-07-15 0001274644 Ocera Therapeutics, Inc. OCRX 0001207786 DOVEY BRIAN H C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON NJ 08542 0 0 1 0 Common Stock 2013-07-15 4 P 0 988285 6.0264 A 988285 I By Domain Partners VIII, L.P. Common Stock 2013-07-15 4 P 0 7333 6.0264 A 7333 I By DP VIII Associates, L.P. Common Stock 2013-07-15 4 P 0 331873 6.0264 A 1897336 I By Domain Partners VI, L.P. Common Stock 15731 I By DP VI Associates, L.P. Common Stock 47963 I By Domain Associates, LLC The Reporting Person is a Managing Member of (i) One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P., (ii) One Palmer Square Associates VI, LLC, which is the sole general partner of Domain Partners VI, L.P. and DP VI Associates, L.P., and (iii) Domain Associates, LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her. The Issuer changed its name from Tranzyme, Inc. [TZYM] to Ocera Therapeutics, Inc. on July 15, 2013. /s/Kathleen K. Schoemaker, Attorney-in-Fact 2013-07-15